News

Starsource Multitrade Limited, formerly known as Chemo Pharma Laboratories Limited, will hold a board meeting on Friday, August 14, 2026, to consider and approve the unaudited financial results for the first quarter ended June 30, 2026, along with the limited review report thereon. Trading window for designated persons is closed from July 1, 2026, and will reopen 48 hours after the announcement of the financial results.

Net Loss of Starsource Multitrade reported to Rs 0.07 crore in the quarter ended March 2026 as against net loss of Rs 0.34 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 and during the previous quarter ended March 2025.For the full year,net loss reported to Rs 11.85 crore in the year ended March 2026 as against net profit of Rs 0.34 crore during the previous year ended March 2025. Sales reported to Rs 0.53 crore in the year ended March 2026. There were no Sales reported during the previous year ended March 2025.Powered by Capital Market - Live News

Starsource Multitrade will hold a meeting of the Board of Directors of the Company on 29 May 2026.

Net Loss of Starsource Multitrade reported to Rs 0.09 crore in the quarter ended December 2025 as against net loss of Rs 0.17 crore during the previous quarter ended December 2024. There were no Sales reported in the quarter ended December 2025 and during the previous quarter ended December 2024.Powered by Capital Market - Live News

Starsource Multitrade will hold a meeting of the Board of Directors of the Company on 12 February 2026.Powered by Capital Market - Live News